360 related articles for article (PubMed ID: 20347242)
21. Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases.
Karoui M; Vigano L; Goyer P; Ferrero A; Luciani A; Aglietta M; Delbaldo C; Cirillo S; Capussotti L; Cherqui D
Br J Surg; 2010 Sep; 97(9):1354-62. PubMed ID: 20603857
[TBL] [Abstract][Full Text] [Related]
22. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors.
Curtiss SI; Mor E; Schwartz ME; Sung MW; Hytiroglou P; Thung SN; Sheiner PA; Emre S; Miller CM
J Am Coll Surg; 1995 Feb; 180(2):184-7. PubMed ID: 7850052
[TBL] [Abstract][Full Text] [Related]
23. [Is liver transplantation as surgical therapy concept in metastases of neuroendocrine tumors justified?].
Lang H; Oldhafer KJ; Schlitt HJ; Scheumann GF; Ringe B; Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():416-8. PubMed ID: 9101890
[TBL] [Abstract][Full Text] [Related]
24. [Liver surgery: what is feasible?].
Ladurner R; Königsrainer A
Zentralbl Chir; 2007 Aug; 132(4):274-80. PubMed ID: 17724627
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic alternatives in metastatic neuroendocrine tumors.
Miller CA; Ellison EC
Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine liver metastases.
Reddy SK; Clary BM
Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
Berber E; Flesher N; Siperstein AE
World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of neuroendocrine tumors (including carcinoid).
Doherty G
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):32-6. PubMed ID: 23183358
[TBL] [Abstract][Full Text] [Related]
29. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection.
Kianmanesh R; Sauvanet A; Hentic O; Couvelard A; Lévy P; Vilgrain V; Ruszniewski P; Belghiti J
Ann Surg; 2008 Apr; 247(4):659-65. PubMed ID: 18362629
[TBL] [Abstract][Full Text] [Related]
30. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours.
Pascher A; Klupp J; Neuhaus P
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):637-48. PubMed ID: 16183532
[TBL] [Abstract][Full Text] [Related]
31. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
32. Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach.
Saxena A; Chua TC; Sarkar A; Chu F; Liauw W; Zhao J; Morris DL
Surgery; 2011 Feb; 149(2):209-20. PubMed ID: 20674950
[TBL] [Abstract][Full Text] [Related]
33. Making unresectable hepatic colorectal metastases resectable--does it work?
Vauthey JN; Zorzi D; Pawlik TM
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S118-22. PubMed ID: 16399448
[TBL] [Abstract][Full Text] [Related]
34. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
[TBL] [Abstract][Full Text] [Related]
35. Aggressive surgery for liver metastases from gastrointestinal stromal tumors.
Shima Y; Horimi T; Ishikawa T; Ichikawa J; Okabayashi T; Nishioka Y; Hamada M; Shibuya Y; Ishii T; Ito M
J Hepatobiliary Pancreat Surg; 2003; 10(1):77-80. PubMed ID: 12827476
[TBL] [Abstract][Full Text] [Related]
36. The surgical management of neuroendocrine tumour hepatic metastases.
Pathak S; Dash I; Taylor MR; Poston GJ
Eur J Surg Oncol; 2013 Mar; 39(3):224-8. PubMed ID: 23290582
[TBL] [Abstract][Full Text] [Related]
37. Aggressive surgery for metastatic liver neuroendocrine tumors.
Norton JA; Warren RS; Kelly MG; Zuraek MB; Jensen RT
Surgery; 2003 Dec; 134(6):1057-63; discussion 1063-5. PubMed ID: 14668741
[TBL] [Abstract][Full Text] [Related]
38. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
[TBL] [Abstract][Full Text] [Related]
39. [Metastatic disease of the liver: surgical perspective].
Mercado MA; Medina H; Rossano A; Acosta E; Rodríguez M; Chan C; Orozco H
Rev Gastroenterol Mex; 1997; 62(3):235-8. PubMed ID: 9480532
[TBL] [Abstract][Full Text] [Related]
40. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
